• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form S-8 POS filed by Lam Research Corporation

    11/6/25 4:27:44 PM ET
    $LRCX
    Industrial Machinery/Components
    Technology
    Get the next $LRCX alert in real time by email
    S-8 POS 1 ef20057821_s8pos.htm S-8 POS
    Registration No. 333-207844
    As filed with the Securities and Exchange Commission on November 6, 2025
     

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549



    POST-EFFECTIVE AMENDMENT NO. 1
    TO
    FORM S-8
    REGISTRATION STATEMENT
    UNDER
    THE SECURITIES ACT OF 1933



    LAM RESEARCH CORPORATION
    (Exact name of Registrant as specified in its charter)



    Delaware
     
    94-2634797
    (State or other jurisdiction of incorporation or organization)
     
    (IRS Employer Identification No.)

    4650 Cushing Parkway
    Fremont, California
     
    94538
    (Address of Principal Executive Offices)
     
    (Zip Code)

    LAM RESEARCH CORPORATION 2025 STOCK INCENTIVE PLAN
    LAM RESEARCH CORPORATION 2015 STOCK INCENTIVE PLAN
    (Full title of the plans)

    Ava A. Harter
    Senior Vice President and Chief Legal Officer
    Lam Research Corporation
    4650 Cushing Parkway
    Fremont, California 94538
    (Name and address of agent for service)

    (510) 572-0200
    (Telephone number, including area code, of agent for service)

    Copy to:
    Jeremy Cleveland
    Jones Day
    1755 Embarcadero Road
    Palo Alto, CA 94303


     
    Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

    Large accelerated filer
    ☒
    Accelerated filer
    ☐
           
    Non-accelerated filer
    ☐
    Smaller reporting company
    ☐
           
       
    Emerging growth company
    ☐
     
    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐



    EXPLANATORY NOTE
     
    Lam Research Corporation (the “Registrant”) previously filed its Registration Statement on Form S-8 with the Securities and Exchange Commission (the “SEC” or “Commission”) on November 6, 2015 (Commission File No.333-207844) (the “Prior Registration Statement”) to register the offer of 18,000,000 new shares of common stock, par value $0.001 per share, of the Registrant (the “Common Stock”) pursuant to the Registrant’s 2015 Stock Incentive Plan (the “2015 Plan”). On October 2, 2024, the Registrant effected a 10-for-1 stock split of the Common Stock and a proportional increase in the number of authorized shares.
     
    At the Registrant’s 2025 Annual Meeting of Stockholders on November 4, 2025, the stockholders of the Registrant approved the adoption of the Lam Research Corporation 2025 Stock Incentive Plan (the “2025 Plan”) as successor to the 2015 Plan, effective on November 4, 2025 (the “2025 Plan Effective Date”). On or after the 2025 Plan Effective Date, no new awards will be granted under the 2015 Plan. The outstanding awards under the 2015 Plan continue unaffected following the 2025 Plan Effective Date and will remain subject to the terms of the 2015 Plan notwithstanding the termination of the 2015 Plan. Any shares of Common Stock that are available for grant or would otherwise return to the 2015 Plan as a result of the forfeiture, termination, expiration, or cash settlement of awards previously granted under the 2015 Plan will also be available for issuance under the 2025 Plan (collectively, the “Rollover Shares”).
     
    Shortly prior to the 2025 Plan Effective Date, a total of 62,772,164 shares of Common Stock were available for additional awards under the 2015 Plan, and 10,906,926 shares of Common Stock were subject to awards then outstanding under the 2015 Plan, in each case calculated based on the maximum number of shares subject to outstanding performance stock unit awards. The aggregate number of Rollover Shares authorized for issuance under the 2015 Plan that may become authorized for issuance under the 2025 Plan will not exceed 73,679,090 shares. The Registrant is filing this Post-Effective Amendment No. 1 to Form S-8 pursuant to SEC Compliance and Disclosure Interpretation 126.43 to amend the Prior Registration Statement to register the offer of this amount of the Rollover Shares under the 2025 Plan (as such shares would no longer be issuable under the 2015 Plan). In accordance with such SEC interpretation, no new filing fee is due upon the filing of this Post-Effective Amendment No. 1.
     
    PART I
     
    INFORMATION REQUIRED IN THE SECTION 10(a) PROSPECTUS
     
    The information specified in Part I of Form S-8 is omitted from this Registration Statement on Form S-8 in accordance with the provisions of Rule 428 under the Securities Act of 1933, as amended (the “Securities Act”), and the introductory note to Part I of Form S-8. The documents containing the information specified in Part I of Form S-8 will be sent or given to participants in the 2025 Plan covered by this Registration Statement as specified by Rule 428(b)(1) under the Securities Act. These documents and the documents incorporated by reference in this Registration Statement pursuant to Item 3 of Part II below, taken together, constitute a prospectus that meets the requirements of Section 10(a) of the Securities Act.
     
    PART II
     
    INFORMATION REQUIRED IN THE REGISTRATION STATEMENT

    Item 3.
    Incorporation of Documents by Reference.
     
    The following documents, which have been filed by the Registrant with the Commission are hereby incorporated by reference into this Registration Statement:


     
    (a)
    The Registrant’s Annual Report on Form 10-K for the fiscal year ended June 29, 2025 (File No. 000-12933), filed with the Commission on August 11, 2025;

     
    (b)
    The Registrant’s Quarterly Report on Form 10-Q for the quarterly period ended September 28, 2025, filed with the Commission on October 24, 2025;

     
    (c)
    The Registrant’s Current Reports on Form 8-K (File No. 000-12933), filed with the Commission on September 11, 2025, October 22, 2025 and November 6, 2025;

     
    (d)
    Portions of the Registrant’s definitive proxy statement on Schedule 14A filed on September 24, 2025 that are incorporated by reference into Part III of the Registrant’s Annual Report on Form 10-K for the fiscal year ended June 29, 2025; and

     
    (e)
    The description of Registrant’s Common Stock as set forth in Exhibit 4.6 of the Registrant’s Annual Report on Form 10-K for the fiscal year ended June 29, 2025 (File No. 000-12933), filed with the Commission on August 11, 2025, and as set forth in the Registrant’s Registration Statement filed with the Commission on Form 8-B on April 11, 1990 and any amendment or report filed for the purpose of updating such description.

    All documents subsequently filed by the Registrant pursuant to Sections 13(a), 13(c), 14 and 15(d) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), prior to the filing of a post-effective amendment which indicates that all securities offered hereby have been sold or which de-registers all securities then remaining unsold, shall be deemed to be incorporated by reference herein and to be part hereof from the date of filing such documents. The Registrant will not, however, incorporate by reference any documents or portions thereof that are not deemed “filed” with the Commission, including any information furnished pursuant to Item 2.02 or Item 7.01 of the Registrant’s Current Reports on Form 8-K unless, and except to the extent, specified in such reports.
     
    Any statement contained in a document incorporated or deemed to be incorporated by reference herein shall be deemed to be modified or superseded for purposes of this Registration Statement to the extent that a statement contained herein or in any subsequently filed document which also is or is deemed to be incorporated by reference herein modifies or supersedes such statement. Any such statement so modified or superseded shall not be deemed, except as so modified or superseded, to constitute a part of this Registration Statement.

    Item 4.
    Description of Securities.
     
    Not applicable.

    Item 5.
    Interests of Named Experts and Counsel.
     
    Not applicable.

    Item 6.
    Indemnification of Directors and Officers.
     
    Section 145 of the General Corporation Law of the State of Delaware (the “DGCL”) generally provides that all directors and officers (as well as other employees and agents of the corporation) may be indemnified against expenses (including attorneys’ fees), judgments, fines and amounts paid in settlement in connection with certain specified actions, suits or proceedings, whether civil, criminal, administrative or investigative (other than an action by or in the right of the corporation), if they acted in good faith and in a manner they reasonably believed to be in or not opposed to the best interests of the corporation, and, with respect to any criminal action or proceeding, had no reasonable cause to believe their conduct was unlawful. A similar standard of care is applicable in the case of derivative actions in which the action is by or in the right of the corporation, except that indemnification extends only to expenses (including attorneys’ fees) incurred in connection with defense or settlement of an action, and the DGCL requires court approval before there can be any indemnification where the person seeking indemnification has been found liable to the corporation. Section 145 of the DGCL also provides that the rights conferred thereby are not exclusive of any other right to which any person may be entitled under any bylaw, agreement, vote of stockholders or disinterested directors or otherwise, and permits a corporation to advance expenses to or on behalf of a director or officer upon receipt of an undertaking to repay the amounts advanced if it is determined that the person is not entitled to be indemnified.


    Section 102(b)(7) of the DGCL permits the Registrant to provide in its certificate of incorporation that a director or officer of the Registrant shall not be personally liable to the Registrant or its stockholders for monetary damages for breach of fiduciary duty as a director or officer, except (1) with respect to a director or officer, for any breach of the director’s or officer’s duty of loyalty to the Registrant or its stockholders, (2) with respect to a director or officer, for acts or omissions not in good faith or which involve intentional misconduct or a knowing violation of law, (3) with respect to a director, under Section 174 of the DGCL regarding the liability of directors for the unlawful payment of dividend or the unlawful stock purchase or redemption, (4) with respect to a director or officer, for any transaction from which the director or officer derived an improper personal benefit, or (5) with respect to an officer, in any action by or in the right of the corporation.
     
    Section 145 of the DGCL also permits a corporation to purchase and maintain insurance on behalf of any director, officer, employee or agent against any liability asserted against such person acting in his or her capacity, whether or not the corporation would have the power to indemnify such person against such liability. The Registrant provides liability insurance for directors and officers of the Registrant and its subsidiaries. The Registrant has additionally entered into indemnification agreements with each of its Section 16 executive officers and directors.
     
    Article VI of the Registrant’s bylaws provides that the Registrant shall, to the maximum extent and in the manner permitted by the DGCL, indemnify each of its directors and officers against expenses (including attorneys’ fees), judgments, fines, settlements, and other amounts actually and reasonably incurred in connection with any proceeding, arising by reason of the fact that such person is or was a director or officer of the Registrant. The right conferred on any person by Article VI of the Registrant’s bylaws shall not be exclusive of any other rights, which such person may have or hereafter acquired under any statute, the certificate of incorporation, the bylaws, agreement, vote of the stockholders or directors or otherwise.

    Item 7.
    Exemption from Registration Claimed.
     
    Not applicable.

    Item 8.
    Exhibits.

    3.1
    Restated Certificate of Incorporation, dated November 4, 2025 which is incorporated by reference to Exhibit 3.2 to the Registrant’s Current Report on Form 8-K filed on November 6, 2025 (SEC File No. 000-12933).
       
    3.2
    Bylaws of the Registrant, as amended and restated, dated May 20, 2025 which is incorporated by reference to Exhibit 3.1 to the Registrant’s Current Report on Form 8-K filed on May 21, 2025 (SEC File No. 000-12933).
       
    4.1
    Registrant’s 2015 Stock Incentive Plan (incorporated by reference as Appendix B to the Registrant’s Schedule 14A filed on September 21, 2015).
       
    4.2
    Lam Research Corporation 2025 Stock Incentive Plan (incorporated by reference as Appendix A to the Registrant’s Schedule 14A filed on September 24, 2025).
       
    5.1
    Opinion of Jones Day (as to Common Stock originally registered under the 2015 Plan), which is incorporated by reference to Exhibit 5.1 to the Registrant’s Registration Statement on Form S-8 dated November 6, 2015 (SEC File No. 333-207844).
       
    5.2*
    Opinion of Jones Day (as to Rollover Shares from the 2015 Plan being registered hereby under the 2025 Plan).
       
    23.1*
    Consent of Ernst & Young LLP, Independent Registered Public Accounting Firm.
       
    23.2
    Consent of Jones Day (filed as part of Exhibit 5.1).


    23.3*
    Consent of Jones Day (filed as part of Exhibit 5.2).


    24.1*
    Power of Attorney (included on signature page).

    * Filed herewith.


    Item 9.
    Undertakings.
     
    (a) The undersigned Registrant hereby undertakes:
     
    (1) To file, during any period in which offers or sales are being made, a post-effective amendment to this Registration Statement:
     
    (i) To include any prospectus required by Section 10(a)(3) of the Securities Act of 1933;
     
    (ii) To reflect in the prospectus any facts or events arising after the effective date of this Registration Statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in this Registration Statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of a prospectus filed with the Commission pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price represent no more than a 20 percent change in the maximum aggregate offering price set forth in the “Calculation of Registration Fee” table in the effective registration statement; and
     
    (iii) To include any material information with respect to the plan of distribution not previously disclosed in this Registration Statement or any material change to such information in this Registration Statement.
     
    Provided, however, that paragraphs (a)(1)(i) and (a)(1)(ii) shall not apply if the information required to be included in a post-effective amendment by those paragraphs is contained in periodic reports filed with or furnished to the Commission by the Registrant pursuant to Section 13 or Section 15(d) of the Exchange Act that are incorporated by reference in this Registration Statement.
     
    (2) That, for the purpose of determining any liability under the Securities Act of 1933, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.
     
    (3) To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering.
     
    (b) The undersigned Registrant hereby undertakes that, for purposes of determining any liability under the Securities Act of 1933, each filing of the Registrant’s annual report pursuant to Section 13(a) or Section 15(d) of the Exchange Act (and, where applicable, each filing of an employee benefit plan’s annual report pursuant to Section 15(d) of the Exchange Act) that is incorporated by reference in this Registration Statement shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.
     
    (c) Insofar as indemnification for liabilities arising under the Securities Act of 1933 may be permitted to directors, officers and controlling persons of the Registrant pursuant to the foregoing provisions, or otherwise, the Registrant has been advised that in the opinion of the Commission such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the Registrant of expenses incurred or paid by a director, officer, or controlling person of the Registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the Registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue.


    SIGNATURES
     
    Pursuant to the requirements of the Securities Act of 1933, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Post-Effective Amendment No. 1 to the Registration Statement on Form S-8 to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Fremont, State of California, on November 6, 2025.
     
     
    Lam Research Corporation
         
     
    By:
    /s/ Ava A. Harter
       
    Ava A. Harter
       
    Senior Vice President and Chief Legal Officer


    POWER OF ATTORNEY
     
    KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below does hereby constitute and appoint Timothy M. Archer and Douglas R. Bettinger, with full power of substitution, such person’s true and lawful attorneys-in-fact and agents for such person in such person’s name, place and stead, in any and all capacities, to sign any or all amendments (including post-effective amendments) to this Post-Effective Amendment No. 1 to Registration Statement on Form S-8, and to sign any registration statement for the same offering covered by this Registration Statement that is to be effective upon filing pursuant to Rule 462(b) under the Securities Act of 1933, as amended, and all post-effective amendments thereto, and to file the same, with all exhibits thereto, and all documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, full power and authority to do and perform each and every act and thing requisite and necessary to be done in and about the premises in order to effectuate the same as fully, to all intents and purposes, as he, she or such person might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents, each acting alone, or his or her substitute or substitutes, may lawfully do or cause to be done by virtue hereof.
     
    Pursuant to the requirements of the Securities Act of 1933, this Post-Effective Amendment No. 1 to the Registration Statement on Form S-8 has been signed below by the following persons in their respective capacities and on the dates indicated.

    Signature
     
    Title
     
    Date
           
     /s/ Timothy M. Archer  
    President, Chief Executive Officer and Director
    (Principal Executive Officer)
     
    November 6, 2025
    Timothy M. Archer
     

       
     /s/ Douglas R. Bettinger  
    Executive Vice President and Chief Financial
    Officer (Principal Financial Officer)
     
    November 6, 2025
    Douglas R. Bettinger
       
         
     /s/ Christina C. Correia  
    Group Vice President and Chief Accounting Officer
    (Principal Accounting Officer)
     
    November 6, 2025
    Christina C. Correia
       
         
    /s/ Abhijit Y. Talwalkar
     
    Chairman and Director
     
    November 6, 2025
    Abhijit Y. Talwalkar
       
         
     /s/ Sohail U. Ahmed  
    Director

    November 6, 2025
    Sohail U. Ahmed
       
         
     /s/ Eric K. Brandt  
    Director
     
    November 6, 2025
    Eric K. Brandt
       
         
     /s/ Ita M. Brennan  
    Director
     
    November 6, 2025
    Ita M. Brennan
       
         
     /s/ Michael R. Cannon  
    Director
     
    November 6, 2025
    Michael R. Cannon
       
         
     /s/ John M. Dineen  
    Director
     
    November 6, 2025
    John M. Dineen
       
         
     /s/ Mark Fields
    Director

    November 6, 2025
    Mark Fields
       
             
    /s/ Ho Kyu Kang
     
    Director
     
    November 6, 2025
    Ho Kyu Kang
           
             
    /s/ Bethany J. Mayer
     
    Director
     
    November 6, 2025
    Bethany J. Mayer
           
             
    /s/ Jyoti Mehra
     
    Director
     
    November 6, 2025
    Jyoti Mehra
           



    Get the next $LRCX alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $LRCX

    DatePrice TargetRatingAnalyst
    10/23/2025$145.00 → $170.00Buy
    TD Cowen
    9/30/2025$127.00Hold
    HSBC Securities
    9/29/2025$150.00Hold → Buy
    Deutsche Bank
    9/23/2025Overweight → Sector Weight
    KeyBanc Capital Markets
    9/22/2025$125.00Underweight → Equal-Weight
    Morgan Stanley
    9/2/2025$92.00Equal-Weight → Underweight
    Morgan Stanley
    8/14/2025Buy
    Erste Group
    7/31/2025Buy → Hold
    Summit Insights
    More analyst ratings

    $LRCX
    SEC Filings

    View All

    SEC Form S-8 filed by Lam Research Corporation

    S-8 - LAM RESEARCH CORP (0000707549) (Filer)

    11/6/25 4:32:42 PM ET
    $LRCX
    Industrial Machinery/Components
    Technology

    SEC Form S-8 POS filed by Lam Research Corporation

    S-8 POS - LAM RESEARCH CORP (0000707549) (Filer)

    11/6/25 4:27:44 PM ET
    $LRCX
    Industrial Machinery/Components
    Technology

    Lam Research Corporation filed SEC Form 8-K: Material Modification to Rights of Security Holders, Leadership Update, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits

    8-K - LAM RESEARCH CORP (0000707549) (Filer)

    11/6/25 4:02:44 PM ET
    $LRCX
    Industrial Machinery/Components
    Technology

    $LRCX
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Mayer Bethany sold $207,667 worth of shares (1,298 units at $159.99), decreasing direct ownership by 44% to 1,652 units (SEC Form 4)

    4 - LAM RESEARCH CORP (0000707549) (Issuer)

    11/4/25 6:05:17 PM ET
    $LRCX
    Industrial Machinery/Components
    Technology

    Director Kang Ho Kyu covered exercise/tax liability with 664 shares, decreasing direct ownership by 8% to 8,029 units (SEC Form 4)

    4 - LAM RESEARCH CORP (0000707549) (Issuer)

    11/3/25 12:40:03 PM ET
    $LRCX
    Industrial Machinery/Components
    Technology

    Chief Legal Officer Harter Ava exercised 6,010 shares at a strike of $77.04 and sold $1,418,775 worth of shares (9,010 units at $157.47), decreasing direct ownership by 5% to 56,786 units (SEC Form 4)

    4 - LAM RESEARCH CORP (0000707549) (Issuer)

    10/28/25 11:53:01 AM ET
    $LRCX
    Industrial Machinery/Components
    Technology

    $LRCX
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Legal Officer Harter Ava bought $602 worth of shares (9 units at $63.66) and covered exercise/tax liability with 5,270 shares, decreasing direct ownership by 8% to 59,786 units (SEC Form 4)

    4 - LAM RESEARCH CORP (0000707549) (Issuer)

    8/6/25 1:11:26 PM ET
    $LRCX
    Industrial Machinery/Components
    Technology

    $LRCX
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Lam Research Corporation Declares Quarterly Dividend

    FREMONT, Calif., Nov. 6, 2025 /PRNewswire/ -- Lam Research Corporation (NASDAQ:LRCX) today announced that its Board of Directors has approved a quarterly dividend of $0.26 per share of common stock. The dividend payment will be made on January 7, 2026, to holders of record on December 3, 2025. Future dividend payments are subject to review and approval by the Board of Directors. About Lam Research: Lam Research Corporation is a global supplier of innovative wafer fabrication equipment and services to the semiconductor industry. Lam's equipment and services allow customers to build smaller and better performing devices. In fact, today, nearly every advanced chip is built with Lam technology.

    11/6/25 4:05:00 PM ET
    $LRCX
    Industrial Machinery/Components
    Technology

    Lam Research Corporation Reports Financial Results for the Quarter Ended September 28, 2025

    FREMONT, Calif., Oct. 22, 2025 /PRNewswire/ -- Lam Research Corporation (the "Company," "Lam," "Lam Research") today announced financial results for the quarter ended September 28, 2025 (the "September 2025 quarter"). Highlights for the September 2025 quarter were as follows: Revenue of $5.32 billion.U.S. GAAP gross margin of 50.4%, U.S. GAAP operating income as a percentage of revenue of 34.4%, and U.S. GAAP diluted EPS of $1.24.Non-GAAP gross margin of 50.6%, non-GAAP operating income as a percentage of revenue of 35.0%, and non-GAAP diluted EPS of $1.26.Key Financial Data for the Quarters Ended  September 28, 2025 and June 29, 2025 (in thousands, except per-share data, percentages, and ba

    10/22/25 4:05:00 PM ET
    $LRCX
    Industrial Machinery/Components
    Technology

    Lam Research Corporation Announces September Quarter Financial Conference Call

    FREMONT, Calif., Oct. 1, 2025 /PRNewswire/ -- Lam Research Corp. (NASDAQ:LRCX) today announced that the company will host its quarterly financial conference call and webcast on Wednesday, October 22, 2025, beginning at 2:00 p.m. Pacific Daylight Time (5:00 p.m. Eastern Daylight Time). Webcast:                              To access the webcast, visit the Investors section of Lam's website at http://www.lamresearch.com and click on the Investors/Investors Overview/Events & Presentations section to view the details. Replay Information:        A webcast replay will be available o

    10/1/25 4:05:00 PM ET
    $LRCX
    Industrial Machinery/Components
    Technology

    $LRCX
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    TD Cowen reiterated coverage on Lam Research with a new price target

    TD Cowen reiterated coverage of Lam Research with a rating of Buy and set a new price target of $170.00 from $145.00 previously

    10/23/25 6:36:09 AM ET
    $LRCX
    Industrial Machinery/Components
    Technology

    HSBC Securities initiated coverage on Lam Research with a new price target

    HSBC Securities initiated coverage of Lam Research with a rating of Hold and set a new price target of $127.00

    9/30/25 8:56:14 AM ET
    $LRCX
    Industrial Machinery/Components
    Technology

    Lam Research upgraded by Deutsche Bank with a new price target

    Deutsche Bank upgraded Lam Research from Hold to Buy and set a new price target of $150.00

    9/29/25 9:49:07 AM ET
    $LRCX
    Industrial Machinery/Components
    Technology

    $LRCX
    Financials

    Live finance-specific insights

    View All

    Lam Research Corporation Declares Quarterly Dividend

    FREMONT, Calif., Nov. 6, 2025 /PRNewswire/ -- Lam Research Corporation (NASDAQ:LRCX) today announced that its Board of Directors has approved a quarterly dividend of $0.26 per share of common stock. The dividend payment will be made on January 7, 2026, to holders of record on December 3, 2025. Future dividend payments are subject to review and approval by the Board of Directors. About Lam Research: Lam Research Corporation is a global supplier of innovative wafer fabrication equipment and services to the semiconductor industry. Lam's equipment and services allow customers to build smaller and better performing devices. In fact, today, nearly every advanced chip is built with Lam technology.

    11/6/25 4:05:00 PM ET
    $LRCX
    Industrial Machinery/Components
    Technology

    Lam Research Corporation Reports Financial Results for the Quarter Ended September 28, 2025

    FREMONT, Calif., Oct. 22, 2025 /PRNewswire/ -- Lam Research Corporation (the "Company," "Lam," "Lam Research") today announced financial results for the quarter ended September 28, 2025 (the "September 2025 quarter"). Highlights for the September 2025 quarter were as follows: Revenue of $5.32 billion.U.S. GAAP gross margin of 50.4%, U.S. GAAP operating income as a percentage of revenue of 34.4%, and U.S. GAAP diluted EPS of $1.24.Non-GAAP gross margin of 50.6%, non-GAAP operating income as a percentage of revenue of 35.0%, and non-GAAP diluted EPS of $1.26.Key Financial Data for the Quarters Ended  September 28, 2025 and June 29, 2025 (in thousands, except per-share data, percentages, and ba

    10/22/25 4:05:00 PM ET
    $LRCX
    Industrial Machinery/Components
    Technology

    Lam Research Corporation Announces September Quarter Financial Conference Call

    FREMONT, Calif., Oct. 1, 2025 /PRNewswire/ -- Lam Research Corp. (NASDAQ:LRCX) today announced that the company will host its quarterly financial conference call and webcast on Wednesday, October 22, 2025, beginning at 2:00 p.m. Pacific Daylight Time (5:00 p.m. Eastern Daylight Time). Webcast:                              To access the webcast, visit the Investors section of Lam's website at http://www.lamresearch.com and click on the Investors/Investors Overview/Events & Presentations section to view the details. Replay Information:        A webcast replay will be available o

    10/1/25 4:05:00 PM ET
    $LRCX
    Industrial Machinery/Components
    Technology

    $LRCX
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Lam Research Corporation (Amendment)

    SC 13G/A - LAM RESEARCH CORP (0000707549) (Subject)

    2/13/24 5:08:11 PM ET
    $LRCX
    Industrial Machinery/Components
    Technology

    SEC Form SC 13G/A filed by Lam Research Corporation (Amendment)

    SC 13G/A - LAM RESEARCH CORP (0000707549) (Subject)

    2/10/22 8:22:19 AM ET
    $LRCX
    Industrial Machinery/Components
    Technology

    SEC Form SC 13G/A filed by Lam Research Corporation (Amendment)

    SC 13G/A - LAM RESEARCH CORP (0000707549) (Subject)

    2/9/22 9:22:50 AM ET
    $LRCX
    Industrial Machinery/Components
    Technology

    $LRCX
    Leadership Updates

    Live Leadership Updates

    View All

    Lam Research Appoints Ita Brennan and Mark Fields to Board of Directors

    FREMONT, Calif., Aug. 30, 2024 /PRNewswire/ -- Lam Research Corp. (NASDAQ:LRCX) today announced that Ita Brennan and Mark Fields have joined its board of directors, effective August 30, 2024. Brennan brings to the board significant senior executive-level financial management expertise in the technology industry. Most recently, she was Senior Vice President and Chief Financial Officer (CFO) of Arista Networks. Brennan previously held CFO roles at QuantumScape Corporation and Infinera Corporation, where she also served as Vice President of Finance and Corporate Controller. Earli

    8/30/24 4:05:00 PM ET
    $LRCX
    Industrial Machinery/Components
    Technology

    Lam Research Appoints Ava Harter as Chief Legal Officer

    FREMONT, Calif., July 16, 2024 /PRNewswire/ -- Lam Research Corp. (NASDAQ:LRCX) today announced that Ava Harter has joined its executive leadership team as senior vice president and chief legal officer. Reporting to President and Chief Executive Officer Tim Archer, Harter will oversee all of Lam's legal functions as well as government and regulatory affairs. Harter most recently served as executive vice president and chief legal officer at Whirlpool Corporation where she held enterprise-wide responsibility for global legal matters, as well as security and claims for the compan

    7/16/24 9:00:00 AM ET
    $LRCX
    Industrial Machinery/Components
    Technology

    Lam Research Appoints General Electric Alum John M. Dineen to Board of Directors

    FREMONT, Calif., Aug. 24, 2023 /PRNewswire/ -- Lam Research Corp. (NASDAQ:LRCX) today announced that John M. Dineen has joined its board of directors, effective August 24, 2023. Dineen brings to Lam extensive experience in technology, operations, and international business management, including previously serving in multiple executive leadership roles at General Electric Company (GE). During his three-decade career at GE, Dineen was responsible for a broad range of business lines and tens of thousands of employees across the global company. Most recently, Dineen served as Pres

    8/24/23 4:00:00 PM ET
    $LRCX
    Industrial Machinery/Components
    Technology